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Abstract 
Multimodal pain management is the use of combinations of medications from different 
classes or medications with different routes of delivery to optimize pain relief.  The 
adjunctive use of multiple analgesic agents is associated with better pain relief and fewer 
adverse effects.   Intravenous acetaminophen offers a relatively low risk, safe adjunct to 
multimodal therapy. A comparative retrospective chart review showed that adult patients 
undergoing laparoscopic appendectomy or cholecystectomy surgery who received 
intravenous acetaminophen in the operating room had a reduced opioid requirement 
directly after surgery, in the post anesthesia care unit.  A total of 34 doses of opioids 
(Fentanyl and Dilaudid) were given to the group who received the intravenous 
acetaminophen as compared to 65 doses of the same opioids given to the group that did 
not. Since only two surgical procedures were studied, the results may not be applicable to 
other surgical procedures. Additionally, the small sample size (60 patient charts) was a 
noted limitation. Data is consistent with previous studies supporting the use of 
intravenous acetaminophen to help reduce the amount of opioid use postoperatively 
Because of its relatively safe profile, intravenous acetaminophen should be thoughtfully 
considered when addressing pain management in the operative setting. 
Keywords: postoperative pain, acetaminophen injection, acetaminophen IV, intravenous 
paracetamol, laparoscopic surgery and IV acetaminophen. 
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Statement of Problem 
Ambulatory surgical procedures now make up 70% of the total volume of 
hospital-based elective surgical procedures.  Postoperative pain, nausea, and vomiting are 
the most common factors leading to delays in outpatient discharge and admissions to the 
hospital following ambulatory surgery.1   Multimodal pain management, also known as 
balanced analgesia, is defined as using combinations of medications from different 
classes or medications with different routes of delivery to optimize pain relief and 
minimize adverse effects.2   It is fast replacing traditional pain treatment options.3  Pain 
control regimens should not be standardized but tailored to the needs of the individual 
patient, taking into account medical, psychological, and physical condition, age, level of 
fear or anxiety, surgical procedure, personal preference and response to agents given.4 
The adjunctive use of multiple analgesic agents is associated with better pain relief, fewer 
significant adverse effects, facilitation of earlier recovery and improved patient outcomes 
and satisfaction.5  
Literature Review 
Opioids have long been the mainstay of postoperative pain, but the long list of 
associated adverse effects has given support to the multimodal approach to pain 
management. Treatment plans that use only opioids run the risk of intolerable and 
dangerous adverse effects.  Common side effects of opioid administration include 
sedation, dizziness, nausea, vomiting, constipation, physical dependence, tolerance and 
respiratory depression.6  The financial burden of these side effects can be seen in 
increased lengths of hospitalization stay, unexpected admission to the hospital, 
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administration of additional medications to treat the side effects, the potential for 
unexpected intubation to protect the airway in the event of  over-sedation, and an 
abundance of additional burdens should the patient become opioid dependent.  
Additionally, opioid-induced hyperalgesia, a condition in which increasing dosages of 
opioid consumption result in an increased sensitivity to pain, can result.7 
Multimodal analgesia, utilizing regional analgesic techniques, where possible, and 
non-opioid analgesics, appears to represent a viable strategy to decrease systemic opioid 
consumption and improve postoperative analgesia.8 In the United States (US), there are a 
number of nonopioid oral analgesics that, given alone or in combination with opioids, are 
approved and frequently used for acute pain management.  While these agents are 
typically not sufficient to treat moderate-to-severe pain by themselves, they are useful 
adjuncts to opioids.9   The American Society of Anesthesiologists recommended that, 
unless contraindicated, all post surgical patients should receive an around-the-clock 
regimen of a non-opioid agent.10 
Until the Federal Drug Administration (FDA) approved intravenous 
acetaminophen in 2010, there were only two approved intravenous non-opioid analgesics 
available for use for multimodal pain management: ketorolac and ibuprofen, both of 
which are NSAIDs.   Intravenous (IV) NSAIDs have potential adverse events as well, 
including bleeding and renal toxicity, which limits their use in the perioperative setting.11 
Acetaminophen is the most widely used analgesic and antipyretic in the US, and is 
considered the first line drug of choice by the World Health Organization (WHO). It has 
been used in Europe for many years under the generic name paracetamol.  Intravenous 
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acetaminophen represents a relatively new drug for the short-term treatment of mild to 
moderate pain, and moderate to severe pain with adjunctive opioid use.  Acetaminophen 
injection, which is marketed in the US as Ofirmev, provides a significant level of 
analgesia after a 15 minute infusion.12   Acetaminophen IV now provides another 
therapeutic option for hospitalized patients unable to take oral medications, particularly in 
the peri-operative setting.13  
  Intravenous acetaminophen is administered as a 15 minute infusion.  The 
recommended dosage in adults and adolescents weighing more than fifty kilograms is one 
gram, up to four times per day, with a minimum interval of four hours between doses and 
a maximum daily dose of four grams.14    The advantage of using IV acetaminophen in a 
multimodal approach is that it is safe to use in conjunction with other drugs, and has few 
clinically significant drug interactions.15  Its efficacy and tolerability are well established 
and in contrast with opioid analgesics, it has a favorable safety profile.16  Unlike NSAIDs, 
it does not produce gastrointestinal damage. It should be used with caution in patients 
with hepatic impairment or active hepatic disease, alcoholism, chronic malnutrition, 
severe hypovolemia or severe renal impairment, and it should not be used in patients with 
acetaminophen allergy.17While the mechanism of acetaminophen-mediated pain relief is 
still not completely understood, it has been shown that it rapidly enters the intact central 
nervous system (CNS) and the majority of the mechanisms involved in analgesia occur in 
the CNS.18 
  Wininger and associates (2010) conducted a randomized, double-blind, placebo-
controlled, parallel-group study at 17 US sites to evaluate the analgesic efficacy and 
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safety of repeated doses of two dosing regimens of IV acetaminophen compared with 
placebo over 24 hours in subjects with moderate to severe pain after abdominal 
laparoscopic surgery.  A total of 244 subjects were randomized.  Both regimens of IV 
acetaminophen (1000 milligrams every six hours vs. 650 milligrams every four hours)  
were associated with statistically significant analgesic efficacy compared with placebo 
and were well tolerated.  These results are consistent with those of previously published 
studies in which IV acetaminophen was reported to be more effective than placebo and 
comparable to several nonopioid and opioid analgesics in the treatment of postoperative 
acute pain in a wide variety of surgical settings, ranging from tonsillectomy and 
endoscopic sinus surgery to spine and cardiac surgery. 
Marcario and Royal (2010) performed a literature review of randomized clinical 
trials of IV acetaminophen for acute postoperative pain.   
Sixteen articles from nine countries published between 2005 and 2010 met 
inclusion criteria and had a total of 1,464 patients.  In seven of the eight studies where IV 
acetaminophen was compared with an active comparative medication, IV acetaminophen 
was found to have similar analgesic outcomes.  Three of the eight studies also found IV 
acetaminophen resulted in a significant reduction in mean opioid consumption.  Twelve 
of 14 placebo-controlled studies found that IV acetaminophen patients had improved pain 
relief.  The limitations of the studies reviewed were small sample size (only 5 of the 16 
studies included more than 40 patients in the acetaminophen group).  Additionally, 
because the best analgesic approach needs to be individualized to the specific surgical 
procedure, results from a specific study may not be applicable to other surgery types or 
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when other analgesic interventions such as nerve blocks are added to a multimodal 
approach.19  
Clinically, the goal is to advance simple, safe, effective therapies that will reduce 
postoperative pain. Reduction of pain and reduction of adverse side effects ultimately 
leads to safe, effective patient outcomes. The purpose of this project was to investigate 
the relationship between the use of IV acetaminophen in the operating room (OR) and the 
opioid requirement in the post anesthesia care unit (PACU) in patients undergoing 
laparoscopic appendectomies and laparoscopic cholecystectomies. 
      
Method 
Study Design 
This study used a two group design.  Group One included subjects who received 
the standard dose of IV acetaminophen in the OR during an appendectomy or 
cholecystectomy and Group Two were subjects who did not receive the IV 
acetaminophen. 
Site and Sample 
          This research study was conducted at a 350 bed acute care hospital in Rhode 
Island.  The sample was selected from subjects over the age of 18 who had undergone 
laparoscopic appendectomies and laparoscopic cholecystectomies and who met the 
inclusion criteria.  Inclusion criteria included adult patients who received 
IVacetaminophen during the course of laparoscopic appendectomy or laparoscopic 
cholecystectomy surgery and who were able to verbally enumerate their level of pain in 
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the post-operative care unit (PACU).  The numeric pain scale 0-10, where 0 equals no 
pain and 10 equals intolerable pain, was used.  Exclusion criteria included patients who 
were opioid dependent prior to surgery, those that used analgesics or alcohol chronically, 
those with chronic hepatic failure, and those with an allergy to acetaminophen as noted 
on the pre-operative interview by the anesthesiologist.  Patients receiving nerve blocks or 
those that have any pain control devices, such as a patient-controlled analgesia (PCA) 
pump or opioid medication patches were also excluded.  Additionally, patients whose 
pain level was documented in a scale other than the numeric pain scale were excluded.  
Procedures  
Approval was obtained from the institutional and RIC IRB.  The student 
researcher developed a data collection tool derived from the review of the literature and 
clinical experience. The written anesthesia record was used to review the pre-operative 
interview data obtained by the anesthesiologist in order to identify potential exclusions. 
The intraoperative record was reviewed to ascertain whether the patient received IV 
acetaminophen in the operating room. The patient electronic record was surveyed to 
obtain the pain scale and medication interventions used in the post anesthesia care unit 
(PACU). including IV acetaminophen and other analgesics.  Pain scores were recorded 
from PACU admission, at 15 minutes, 30 minutes, and every 15 minutes thereafter until 
transfer from PACU to the outpatient area (for those patients going home) or admission 
to a hospital bed (for those patients being admitted).  The total amount of opioid 
analgesia use was collected and compared between the two groups.    
  7 
 
Data analysis included a comparison of the number of patients reporting pain 
between the two groups as well as the number of doses of IV Fentanyl and IV Dilaudid 
given to patients in each group. 
Results 
 A total of 94 charts were reviewed.  Of those, 60 who met eligibility criteria   
were included: 30 who received IV acetaminophen (Group One) and 30 who did not 
receive IV acetaminophen (Group Two).  Table 1 illustrates the number of patients 
reporting pain in each group from arrival to PACU and in 15 minute increments 
thereafter. Of the 30 patients who did NOT receive IV acetaminophen in the OR (Group 
Two), 23 reported pain levels during their stay in the PACU sufficient to require IV 
opioid administration while 7 did not report pain levels requiring opioids.  Of the 30 
patients who did receive the IV acetaminophen (Group One), 16 reported pain levels 
sufficient to require IV opioids, and 14 did not require IV opioids.  Only one patient in 
Group One required an opioid on arrival to PACU, while three patients in Group Two 
had a pain level requiring the use of an IV opioid.   At every time increment, with the 
exception of the 15 minute time period, more patients in Group Two experienced pain 
compared to Group One.  Additionally, over time, Group One had a higher percentage of 
reduction in the number of patients reporting pain compared to Group Two.  
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Table Two illustrates the number of doses of IV Fentanyl that were given between the 
two groups.  The standard dose of Fentanyl was 50 mcg IV, which could be repeated in 
five minutes, for a total of 100 mcg of Fentanyl. A total of 27 doses of IV Fentanyl (50 
mcg) was given to patients who received IV acetaminophen in the OR, as compared to 41 
doses given to the patients who did not.  Additionally, on arrival, at 30 minutes, 60 
minutes and 75 minutes, at least twice as many doses of Fentanyl were given to the group 
not receiving acetaminophen. 
 
Table 2 
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Table 3 compares the number of doses of IV Dilaudid (1 mg) given between the two 
groups.  After the 100 mcg of IV Fentanyl had been administered, the standard was to 
give one milligram of IV Dilaudid, which could be repeated after five minutes, for a total 
of two mgs.  A total of seven doses were administered to the group receiving IV 
acetaminophen as compared to 24 doses given to the group not receiving it.  
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Discussion 
  
 The data presented in this study is consistent with previous studies that supported 
the use of IV acetaminophen intra-operatively to reduce the amount of opioids used 
postoperatively in these two surgical procedures.  In the hospital where the data were  
collected, the standard for pain management is to medicate for pain levels greater than 
three on a  zero to 10 numeric scale.  The data collected and presented in this study 
suggests that patients who receive IV acetaminophen in the OR report less pain in the 
recovery room and, therefore, require less opioid pain medication in these two surgical 
procedures. 
                    This study was a retrospective chart audit, so was limited by the data that 
was documented. The sample size was small and data were collected at one institution; 
further study is indicated.  The author did not examine individual pain levels with each 
reported pain experience, so there is no way of knowing at what reported pain level 
individual patients were medicated. Anecdotally, some surgeons were found to be 
resistant to using IV acetaminophen in the OR if their patients were going home with a 
prescription for pain medication that contained acetaminophen in it.  These surgeons 
verbalized a fear that those patients might exceed the maximum recommended dose of 
four grams of acetaminophen a day.  
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Conclusions and Recommendations. 
Given the relative safety of IV acetaminophen, prior research, and results of this 
study, the author recommends that institutions give careful consideration to the use of IV 
acetaminophen.  The dangers of opioids are well documented, and opioids contribute to 
post-operative and post discharge nausea and vomiting.  Dosing schedules are available 
that take into account the acetaminophen given in the OR and what can be given to 
patients upon discharge to ensure safe dosing.  Safe and effective pain management is a 
critical patient safety goal following any surgical procedure.  The use of IV   
acetaminophen offers a safe adjunct in the multi-modal approach to pain control in the 
surgical setting. The APRN can be influential in policy development, practice change, 
and in working across systems and within teams to promote the use of intravenous 
acetaminophen as an important component in assuring safe and effective pain 
management in the surgical setting. 
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